376 related articles for article (PubMed ID: 8598488)
1. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
2. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
3. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
4. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
5. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
[TBL] [Abstract][Full Text] [Related]
6. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
Elkin G; Prigozhina TB; Slavin S
Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
[TBL] [Abstract][Full Text] [Related]
8. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
[TBL] [Abstract][Full Text] [Related]
10. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
Hayashi H; LeGuern C; Sachs DH; Sykes M
Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
[TBL] [Abstract][Full Text] [Related]
11. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes.
Zorina TD; Subbotin VM; Bertera S; Alexander AM; Haluszczak C; Gambrell B; Bottino R; Styche AJ; Trucco M
Stem Cells; 2003; 21(4):377-88. PubMed ID: 12832692
[TBL] [Abstract][Full Text] [Related]
12. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
Mathieu C; Casteels K; Bouillon R; Waer M
J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
[TBL] [Abstract][Full Text] [Related]
13. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
[TBL] [Abstract][Full Text] [Related]
14. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) --> NOD] mixed allogeneic bone marrow chimeras.
Takao F; Yasumizu R; Than S; Ohnishi-Inoue Y; Sigiura K; Inaba M; Ikehara S
Immunobiology; 1995 Nov; 194(4-5):376-89. PubMed ID: 8749231
[TBL] [Abstract][Full Text] [Related]
15. Stem cell transplantation for severe autoimmune diseases: progress and problems.
Marmont AM
Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
[TBL] [Abstract][Full Text] [Related]
16. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes.
Zorina TD; Subbotin VM; Bertera S; Alexander AM; Haluszczak C; Styche AJ; Trucco M
Cell Transplant; 2002; 11(2):113-23. PubMed ID: 12099635
[TBL] [Abstract][Full Text] [Related]
17. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
18. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
19. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.
Li H; Kaufman CL; Ildstad ST
Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
